Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|---|
Total reported revenue | 3.0B | 2.7B | 2.8B | 4.5B |
Cost of revenue | 104.7M | 114.7M | 132.0M | 324.5M |
Gross profit | 2.9B | 2.5B | 2.6B | 4.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 447.6M | 393.5M | 451.7M | 1.3B |
Operating income | 1.9B | 1.5B | 1.6B | 1.4B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 26.6M | 10.2M | 25.4M | 85.7M |
Other income expense | — | — | — | — |
Pretax income | 1.9B | 1.5B | 1.7B | 1.4B |
Tax provision | 507.5M | 402.4M | 450.1M | 483.1M |
Net income | 1.4B | 1.1B | 1.3B | 921.5M |
Basic EPS | 3.3 | — | 2.9 | — |
Diluted EPS | 3.1 | — | 2.9 | — |
Basic average shares | 431.7M | — | 432.2M | — |
Diluted average shares | 449.6M | — | 432.2M | — |
EBITDA | 1.9B | 1.8B | 1.8B | 1.5B |
Net income from continuing op. | — | 1.5B | 1.7B | 1.3B |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |